TLN1 and secondary progressive multiple sclerosis: Further stratification of the multiple sclerosis group into the different clinical forms revealed significantly decreased gene expression levels of EZH2, TLN1, and VAV1 in PBMC from RRMS, SPMS, and PPMS patients compared to HC (Fig. 1b).